食用动物非治疗性抗生素市场（依动物类型、产品类型、最终用途、配方和销售管道）——全球预测，2025-2032

预计到 2032 年，食用动物非治疗性抗生素市场将成长至 90.9 亿美元，复合年增长率为 7.39%。

不断发展的科学、监管和商业性背景的战略框架，定义了食用动物非治疗性抗生素使用的现代方法。

受科学发展、消费者期望变化以及监管审查力度加强的影响，围绕食用动物生产中非治疗性抗生素的全球讨论已进入一个更加复杂的阶段。价值链上的相关人员正在努力协调动物健康管理和抗菌药物管理原则，同时保持生产力和供应的连续性。本引言为后续分析提供了背景，重点介绍了政策发展、产业反应和商业性现实之间的相互作用。

随着科学日益揭示抗生素抗药性及其缓解途径，生产商和供应商面临着采用负责任的使用实践以及替代常规预防和促生长用药的期望。同时，贸易和投入成本的动态正在影响采购决策，促使供应链相关人员重新评估采购弹性和供应商关係。非治疗性抗生素的使用不再只是一个兽医问题，而是一个与法规合规性、品牌声誉、动物福利和营运韧性相互交织的策略风险和机会。

本执行摘要的其余部分以此为基础，研究市场变化、关税的贸易影响、细分层面的细微差别、区域动态、竞争情报、建议的行动和调查方法，始终检验基于证据的决策和组织可以部署的实际步骤，以推进向减少对非治疗性抗生素的依赖的转变，同时保护动物生产力和业务连续性。

科学证据、消费者期望和技术进步如何改变食用动物生产的管理实践和商业策略

近年来，一系列变革性变化重塑了非治疗性抗生素在畜牧生产中的认知、监管和使用方式。首先，科学共识和监测数据已将抗生素抗药性从一个小众问题提升为跨部门公共卫生优先事项，促使兽医和食品安全部门建立更强有力的管理框架并修订指南。因此，行业实践正在不断调整，许多大型生产商和零售商正在正式製定抗生素使用政策，并加快替代干预措施的测试。

其次，消费者偏好加剧了商业性压力。对透明度的要求以及对标籤要求的不断提高，促使品牌透过抗生素使用声明进行差异化，推动采购变革，并根据管理目标将产品定位为高端产品。第三，育种、快速诊断和疫苗研发的技术进步正在扩展套件，以减少常规预防性使用，并实现有针对性的治疗性介入。然而，这些工具的采用将因生产系统、规模和资本密集度而异。

最后，供应链和贸易动态正在同步演变。垂直整合、合约製造模式和零售商主导的采购要求日益增长，而风险管理策略通常将监管轨迹和声誉风险纳入考虑。总而言之，这些转变对于那些能够采用基于科学的管理模式、证明供应链可追溯性并投资于非治疗性抗生素用途的可扩展替代方案的公司来说，既带来了营运挑战，也带来了战略机会。

评估2025年关税调整后，整个价值链的投入来源、供应弹性和管理投资的营运可行性将如何变化

2025年生效的关税政策调整进一步加剧了畜牧业相关投入品和最终产品的贸易和供应平衡，影响了成本结构和采购决策，并间接影响了非治疗性抗生素的使用模式。某些动物用药品和饲料原料的关税改变了相对价格，促使一些生产商重新评估其采购区域，并加速了供应多元化策略。这些贸易变化并非孤立存在，而是与国内监管方式和农场层面的管理选择相互影响。

对于净利率微薄或替代投入管道有限的生产商而言，关税带来的成本压力可能会限制对强化管理技术的投资，例如快速诊断、强化生物安全基础设施和新型疫苗平台。相反，拥有一体化供应链和大规模采购的企业可以透过将采购转向提供符合管理要求的投入的供应商来增强其长期竞争力。关税对各地区的影响并不均衡，导致反应不对称，有些供应丛集加速国内替代，而有些则深化与低成本丛集的贸易伙伴关係。

重要的是，关税变化也影响经销商和饲料厂的策略。分销网络正在调整库存和合约条款以降低波动性，饲料製造商也在重新评估其配方，以便在原料价格波动的情况下保持营养充足。总体而言，2025 年关税的累积效应正在提高韧性和适应性的策略性溢价，这使得主动的管理投资和供应链重新设计对于寻求同时管理合规性和商业绩效的相关人员而言比以往任何时候都更加重要。

特定领域的见解揭示了动物类型、产品类别、给药方法、最终用途、配方形式和分销管道如何决定管理途径和采用障碍

细粒度细分显示，避免常规非治疗性抗生素使用的途径因动物类型、产品类别、应用模式、最终用途、配方和销售管道而异。根据产品类型，水产养殖、牛、家禽和猪等生产系统具有不同的流行病学、管理节奏和资本需求，这取决于可行的管理干预措施。家禽和猪养殖系统面临的压力和机会与家牛和水产养殖不同，因为它们的饲养密度通常较高，生产週期较短。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

• 受零售商要求和消费者对无抗生素肉品的需求所推动，抗生素管理计画正在不断扩大
• 欧盟和北美正在加强牲畜非治疗性抗生素的使用限制
• 农场微生物组监测创新，优化抗生素减少策略
• 主要家禽市场迅速采用益生菌和植物来源物质等替代生长促进剂
• 官民合作关係激增，用于资助养猪生产中抗生素替代品的研究
• 进口商强制实施的无抗生素认证标准正在改变全球肉类贸易的动态

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 食用动物非治疗性抗生素市场（依动物类型）

• 水产养殖
• 牛
• 家禽
• 猪

9. 食用动物非治疗性抗生素市场（依产品类型）

• Aminoglycosides
  • 庆大霉素
  • 新霉素
  • 链霉素
• 大环内酯类
  • 红霉素
  • 替米考星
  • 泰乐菌素
• 青霉素
  • 阿莫西林
  • Ampicillin
  • 青霉素G
• 磺胺类药物
  • 磺胺嘧啶
  • 磺胺二甲嘧啶
  • 磺胺甲噁唑
• 四环霉素
  • 四环霉素
  • 四环霉素
  • 四环霉素

10. 食用动物非治疗性抗生素市场（依最终用途）

• 餵食期间
• 水下

11. 食用动物非治疗性抗生素市场（依最终用途）

• 促进生长
• 预防

12. 食用动物非治疗性抗生素市场（依配方）

• 饲料添加剂
• 口服悬浮液
• 水溶性粉末

13. 食用动物非治疗性抗生素市场（依销售管道）

• 饲料厂
• 零售药局
• 兽药经销商

14. 食用动物非治疗性抗生素市场（按地区）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

15. 食用动物非治疗性抗生素市场（依类别）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

16. 各国食用动物非治疗性抗生素市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十七章竞争格局

• 2024年市占率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Virbac SA
  • Vetoquinol SA
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation
  • Huvepharma SA

The Non-Therapeutic Antibiotics for Food Animals Market is projected to grow by USD 9.09 billion at a CAGR of 7.39% by 2032.

A strategic framing of the evolving scientific, regulatory, and commercial context that defines contemporary approaches to non-therapeutic antibiotic use in food animals

The global conversation around non-therapeutic antibiotics in food animal production has entered a more complex phase, shaped by evolving science, shifting consumer expectations, and heightened regulatory scrutiny. Stakeholders across the value chain are contending with the need to reconcile animal health management with antimicrobial stewardship principles, while sustaining productivity and supply continuity. This introduction lays out the context for the analysis that follows, highlighting the interplay between policy developments, industry responses, and commercial realities.

As science increasingly clarifies pathways for resistance and mitigations, producers and suppliers face expectations to adopt responsible use practices and alternatives to routine prophylactic and growth-promotion uses. At the same time, trade and input cost dynamics are influencing procurement and sourcing decisions, prompting supply chain actors to reassess procurement flexibility and supplier relationships. This section establishes a common baseline: non-therapeutic antibiotic use is no longer a narrow veterinary matter but a strategic risk and opportunity that intersects regulatory compliance, brand reputation, animal welfare, and operational resilience.

The remainder of this executive summary builds from this foundation to examine transformative market shifts, tariff-driven trade implications, segmentation-level nuances, regional dynamics, competitive intelligence, recommended actions, and research methodology. Throughout, emphasis is placed on evidence-based decision-making and practical levers organizations can deploy to navigate the transition toward reduced non-therapeutic antibiotic reliance while safeguarding animal productivity and business continuity.

How converging scientific evidence, consumer expectations, and technological advances are transforming stewardship practices and commercial strategies in food animal production

Recent years have seen a sequence of transformative shifts that are reshaping how non-therapeutic antibiotics are perceived, regulated, and used across animal agriculture. First, scientific consensus and surveillance data have elevated antimicrobial resistance from a niche concern to a cross-sectoral public health priority, prompting more robust stewardship frameworks and revised guidelines from veterinary and food safety authorities. Consequently, industry practices are adapting, with many large producers and retailers formalizing antibiotic use policies and accelerating trials of alternative interventions.

Second, consumer preferences are exerting palpable commercial pressure. Increased transparency demands and labeling expectations are incentivizing brands to differentiate through claims about antibiotic use, driving procurement changes and premium positioning for products aligned with stewardship goals. Third, technological advances in husbandry, rapid diagnostics, and vaccine development are expanding the toolkit available to reduce routine prophylactic use and to enable targeted therapeutic interventions. Adoption of these tools, however, varies by production system, scale, and capital intensity.

Finally, supply chain and trade dynamics are evolving in parallel. Vertical integration, contract production models, and retailer-led sourcing requirements are intensifying, while risk management strategies now routinely incorporate regulatory trajectory and reputational exposure. Taken together, these shifts create both operational challenges and strategic openings for firms that can deploy science-based stewardship, demonstrate supply chain traceability, and invest in scalable alternatives to non-therapeutic antibiotic use.

An assessment of how 2025 tariff adjustments have reshaped input sourcing, supply resilience, and the operational feasibility of stewardship investments across the value chain

Tariff policy adjustments enacted in 2025 have introduced additional complexity into the trade and supply equation for inputs and finished products related to animal production, influencing cost structures and sourcing decisions that indirectly affect patterns of non-therapeutic antibiotic use. Tariffs on certain veterinary inputs and on feed ingredient flows have altered relative prices, prompting some producers to reassess procurement geographies and to accelerate supply diversification strategies. These trade shifts are not isolated; they interact with domestic regulatory approaches and farm-level operational choices.

For producers with narrow margins or limited access to alternative inputs, tariff-induced cost pressures can constrain investments in stewardship-enhancing technologies such as rapid diagnostics, enhanced biosecurity infrastructure, or novel vaccine platforms. Conversely, companies with integrated supply chains or greater purchasing scale may seize the moment to reconfigure sourcing toward suppliers offering stewardship-compliant inputs, thereby strengthening long-term competitive positioning. Regional differences in tariff impacts have led to asymmetric responses, with some supply clusters accelerating domestic substitution while others deepen trade partnerships with low-cost suppliers.

Importantly, the tariff landscape has also influenced distributor and feed mill strategies. Distribution networks are adjusting inventories and contract terms to buffer volatility, while feed producers reevaluate formulations to maintain nutritional adequacy amid shifting ingredient prices. In the aggregate, the cumulative tariff effects of 2025 have heightened the strategic premium on resilience and adaptability, making proactive stewardship investments and supply chain redesign ever more salient for actors seeking to manage both compliance and commercial performance.

Segment-specific insights revealing how animal type, product classes, administration modes, end-use intents, formulation formats, and distribution channels determine stewardship pathways and adoption barriers

A granular segmentation lens reveals that pathways away from routine non-therapeutic antibiotic use differ markedly by animal type, product class, application mode, end use, formulation, and sales channel. Based on Animal Type, production systems such as Aquaculture, Cattle, Poultry, and Swine each present distinct epidemiology, management rhythms, and capital requirements that condition feasible stewardship interventions. Poultry and swine systems, which often operate at higher stocking densities and shorter production cycles, face different pressures and opportunities compared with cattle or aquaculture operations.

Based on Product Type, the landscape encompasses broad antibiotic classes including Aminoglycosides, Macrolides, Penicillins, Sulfonamides, and Tetracyclines, each with unique pharmacological properties, withdrawal considerations, and routes of historical use. Within Aminoglycosides, gentamicin, neomycin, and streptomycin have served targeted niches; among Macrolides, erythromycin, tilmicosin, and tylosin remain relevant in specific applications. Penicillins such as amoxicillin, ampicillin, and penicillin G continue to be widely employed therapeutically, while Sulfonamides including sulfadiazine, sulfamethazine, and sulfamethoxazole and Tetracyclines such as chlortetracycline, oxytetracycline, and tetracycline each contribute to distinct treatment paradigms. These product-level differences influence withdrawal planning, regulatory risk profiles, and the attractiveness of alternatives.

Based on Application Mode, the two dominant channels are in-feed and in-water administration, and each presents trade-offs for dosing precision, labor, and potential for lower-intensity prophylactic usage. Based on End Use, distinctions between Growth Promotion and Prophylaxis shape stakeholder incentives and regulatory scrutiny. Based on Formulation, feed additives, oral suspensions, and water soluble powders offer differing logistics, shelf-life, and ease of integration into husbandry routines. Finally, Based on Sales Channel, feed mills, retail pharmacies, and veterinary distributors play distinct roles in shaping access, advisory services, and compliance oversight. Understanding these segmentation layers is essential to designing targeted interventions, prioritizing R&D investments, and tailoring policy measures to the operational realities of different producer cohorts.

How regional regulatory frameworks, trade linkages, and production system diversity across the Americas, Europe Middle East & Africa, and Asia-Pacific shape stewardship trajectories and adoption pathways

Regional dynamics exert a strong influence on regulatory approaches, adoption of alternatives, and trade flows, resulting in differentiated strategic priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, an emphasis on consumer transparency and retailer-led sourcing has driven voluntary stewardship initiatives alongside national regulatory measures. North and South American producers are increasingly aligning procurement practices with buyer requirements and investing in traceability to maintain market access and brand differentiation.

In Europe, Middle East & Africa, regulatory frameworks tend to be prescriptive with firm controls on non-therapeutic uses, and enforcement mechanisms have matured in several European countries. This regulatory rigor has stimulated investment in alternatives, improved on-farm biosecurity practices, and tighter integration of veterinary oversight. By contrast, some MEA markets exhibit uneven regulatory enforcement and variable access to veterinary services, generating pockets of elevated risk and opportunity for targeted capacity-building.

Asia-Pacific encompasses a highly heterogeneous set of production systems and policy environments. Rapidly intensifying livestock sectors in parts of the region have created both pressure points around antibiotic use and fertile grounds for scaled alternative technologies. Trade linkages, feed ingredient sourcing, and input supply chains across the Asia-Pacific region interact with local regulatory trajectories, producing a mosaic of adoption rates and stewardship maturity. Understanding these regional contrasts is critical to designing interventions that are technically feasible, culturally appropriate, and economically sustainable.

Insights on competitive positioning and capability clusters that determine which companies can effectively commercialize alternatives and shape stewardship adoption across supply chains

Competitive dynamics and capability profiles among key industry players are reshaping how stewardship obligations translate into operational choices. Leading integrators and suppliers that combine product innovation with strong distribution networks are better positioned to offer bundled solutions that reduce reliance on routine non-therapeutic antibiotics. These actors typically invest in diagnostic services, vaccination programs, and nutrition-led interventions, enabling customers to transition with lower productivity disruption. Mid-sized regional players often compete on service proximity and pricing, and their success depends on aligning advisory capabilities with local husbandry practices.

Veterinary distributors and feed mill operators play pivotal intermediary roles by influencing on-farm access to products and guidance. Those that evolve from transactional sellers to consultative partners can help accelerate adoption of stewardship-friendly formulations and administration practices. Contract production models and branded retail channels are also important; companies with direct procurement influence can enforce supplier standards and catalyze investment in alternative technologies among upstream partners. New entrants offering rapid diagnostics, biosecurity platforms, or novel therapeutics can disrupt established supply patterns, while incumbent firms with deep customer relationships can leverage scale to commercialize alternatives more rapidly. Across the landscape, the winners will be those that integrate technical credibility, supply chain reach, and tailored commercial models to support customers through transition periods.

Practical, prioritized steps for executives to reduce routine antibiotic reliance while protecting productivity, including diagnostics, procurement realignment, and cross-value-chain collaboration

Industry leaders should prioritize a set of actionable measures that balance immediate compliance needs with longer-term resilience and competitiveness. First, invest in enhanced on-farm advisory services and rapid diagnostics to shift decision-making from blanket prophylaxis to targeted therapeutic interventions. This approach preserves animal health outcomes while reducing unnecessary exposure to antibiotics. Second, develop procurement strategies that diversify input sourcing and favor suppliers that provide verifiable stewardship credentials, thereby mitigating tariff-driven and geopolitical supply risks.

Third, accelerate pilots of non-antibiotic alternatives and husbandry innovations, coupling deployment with rigorous data collection to validate efficacy under commercial conditions. Fourth, strengthen collaboration across the value chain-engaging feed mills, veterinary distributors, retailers, and contract producers-to align incentives, clarify responsibility for compliance, and pool resources for training and infrastructure upgrades. Fifth, embed regulatory intelligence and scenario planning into commercial decision processes so that product portfolios and supply agreements remain adaptable to shifting rules and buyer requirements. Finally, communicate transparently with downstream customers and consumers about stewardship progress to build trust and differentiate responsibly. Implementing these measures requires cross-functional coordination and a mix of short-term operational fixes and sustained capability investments.

A transparent synthesis of literature review, stakeholder interviews, and triangulated qualitative analysis that supports the report's sectoral and operational conclusions

The research underpinning this executive summary combines secondary literature review, stakeholder interviews, and structured qualitative analysis to synthesize contemporary trends affecting non-therapeutic antibiotic use in food animal systems. Secondary sources included peer-reviewed scientific literature, regulatory guidance documents, industry white papers, and public surveillance reports to ensure alignment with the latest evidence on antimicrobial resistance, withdrawal protocols, and stewardship frameworks. Primary inputs were gathered through interviews with veterinarians, feed mill managers, distributor executives, producers across species, and trade specialists to capture operational realities and emergent practices.

Analytical methods prioritized triangulation: findings from interviews were cross-checked against regulatory developments and documented case studies to validate themes and identify divergent regional experiences. The segmentation and regional insights derive from mapping production system characteristics onto product usage patterns, distribution networks, and policy settings. While the methodology emphasizes qualitative depth and practical applicability, care was taken to ensure transparency about sources and to highlight areas where data gaps remain. Readers should consider the conclusions as directional and evidence-based, designed to inform strategy development and operational planning rather than to substitute for bespoke due-diligence in specific commercial contexts.

A conclusive synthesis emphasizing evidence-led strategies and collaborative pathways to reconcile stewardship goals with production and commercial imperatives

In conclusion, the trajectory away from routine non-therapeutic antibiotic use in food animal production is driven by an intersection of scientific, regulatory, commercial, and trade forces. Both risk and opportunity are embedded in this transition: risk in the form of compliance exposure, reputational pressures, and potential cost implications; opportunity in the form of market differentiation, improved animal health outcomes through targeted interventions, and strengthened supply chain resilience. Companies that approach the transition strategically-by investing in diagnostics, diversifying procurement, piloting alternatives, and aligning incentives across the value chain-will be better placed to manage short-term disruptions and secure long-term competitive advantage.

Critical to success will be an evidence-led approach that balances animal welfare, productivity, and public health considerations. Collaboration among producers, advisors, distributors, and buyers will accelerate practical solutions and reduce friction. Finally, iterative assessment of policy trajectories and trade dynamics, combined with flexible operational planning, will enable organizations to adapt as the landscape continues to evolve. The insights in this summary aim to support leaders in charting pragmatic pathways that uphold stewardship commitments while sustaining business performance.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Expansion of antibiotic stewardship programs driven by retailer mandates and consumer demand for antibiotic-free meat products
• 5.2. Increasing regulatory restrictions on non-therapeutic antibiotic use in livestock across EU and North America
• 5.3. Technological innovations in on-farm microbiome monitoring to optimize antibiotic usage reduction strategies
• 5.4. Rapid adoption of alternative growth promoters such as probiotics and phytogenics in major poultry markets
• 5.5. Surge of public-private partnerships funding research into antibiotic alternatives for swine production
• 5.6. Shifts in global meat trade dynamics driven by antibiotic-free certification standards imposed by importers

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-Therapeutic Antibiotics for Food Animals Market, by Animal Type

• 8.1. Aquaculture
• 8.2. Cattle
• 8.3. Poultry
• 8.4. Swine

9. Non-Therapeutic Antibiotics for Food Animals Market, by Product Type

• 9.1. Aminoglycosides
  • 9.1.1. Gentamicin
  • 9.1.2. Neomycin
  • 9.1.3. Streptomycin
• 9.2. Macrolides
  • 9.2.1. Erythromycin
  • 9.2.2. Tilmicosin
  • 9.2.3. Tylosin
• 9.3. Penicillins
  • 9.3.1. Amoxicillin
  • 9.3.2. Ampicillin
  • 9.3.3. Penicillin G
• 9.4. Sulfonamides
  • 9.4.1. Sulfadiazine
  • 9.4.2. Sulfamethazine
  • 9.4.3. Sulfamethoxazole
• 9.5. Tetracyclines
  • 9.5.1. Chlortetracycline
  • 9.5.2. Oxytetracycline
  • 9.5.3. Tetracycline

10. Non-Therapeutic Antibiotics for Food Animals Market, by Application Mode

• 10.1. In Feed
• 10.2. In Water

11. Non-Therapeutic Antibiotics for Food Animals Market, by End Use

• 11.1. Growth Promotion
• 11.2. Prophylaxis

12. Non-Therapeutic Antibiotics for Food Animals Market, by Formulation

• 12.1. Feed Additives
• 12.2. Oral Suspensions
• 12.3. Water Soluble Powders

13. Non-Therapeutic Antibiotics for Food Animals Market, by Sales Channel

• 13.1. Feed Mills
• 13.2. Retail Pharmacies
• 13.3. Veterinary Distributors

14. Non-Therapeutic Antibiotics for Food Animals Market, by Region

• 14.1. Americas
  • 14.1.1. North America
  • 14.1.2. Latin America
• 14.2. Europe, Middle East & Africa
  • 14.2.1. Europe
  • 14.2.2. Middle East
  • 14.2.3. Africa
• 14.3. Asia-Pacific

15. Non-Therapeutic Antibiotics for Food Animals Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Non-Therapeutic Antibiotics for Food Animals Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Share Analysis, 2024
• 17.2. FPNV Positioning Matrix, 2024
• 17.3. Competitive Analysis
  • 17.3.1. Zoetis Inc.
  • 17.3.2. Elanco Animal Health Incorporated
  • 17.3.3. Merck & Co., Inc.
  • 17.3.4. Boehringer Ingelheim International GmbH
  • 17.3.5. Ceva Sante Animale S.A.
  • 17.3.6. Virbac S.A.
  • 17.3.7. Vetoquinol S.A.
  • 17.3.8. Dechra Pharmaceuticals PLC
  • 17.3.9. Phibro Animal Health Corporation
  • 17.3.10. Huvepharma S.A.

LIST OF FIGURES

• FIGURE 1. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 32. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NEOMYCIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STREPTOMYCIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ERYTHROMYCIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TILMICOSIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMOXICILLIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY REGION, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY REGION, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN G, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFADIAZINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHAZINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAMETHOXAZOLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CHLORTETRACYCLINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN FEED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IN WATER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PROPHYLAXIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ORAL SUSPENSIONS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER SOLUBLE POWDERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MILLS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 219. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 220. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 225. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 226. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 227. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 228. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 229. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 230. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 231. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 232. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 233. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 234. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 235. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 236. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 237. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 238. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 239. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2024 (USD MILLION)
• TABLE 240. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2025-2032 (USD MILLION)
• TABLE 241. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
• TABLE 242. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2025-2032 (USD MILLION)
• TABLE 243. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2024 (USD MILLION)
• TABLE 244. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2025-2032 (USD MILLION)
• TABLE 245. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2024 (USD MILLION)
• TABLE 246. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2025-2032 (USD MILLION)
• TABLE 247. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2024 (USD MILLION)
• TABLE 248. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2025-2032 (USD MILLION)
• TABLE 249. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
• TABLE 250. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
• TABLE 251. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
• TABLE 252. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
• TABLE 253. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
• TABLE 254. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
• TABLE 255. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 256. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
• TABLE 257. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 258. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 259. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 260. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 261. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 262. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 263. NORTH AMERICA